Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures

Seeliger, Claudine; Karpinski, Katrin; Haug, Alexander T.; Vester, Helen; Schmitt, Andreas; Bauer, Jan S.; van Griensven, Martijn

Affiliations

¹Department of Experimental Trauma Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

²Department of Trauma Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

³Department of Radiology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany

Abstract and keywords

Osteoporosis as a systemic skeletal disorder is characterized by increased bone fragility and the risk of fractures. According to the World Health Organization, osteoporosis is one of the 10 most common diseases and affects approximately 75 million people in Europe, the United States, and Japan. In this context, the identification of specific microRNA (miRNA) signatures is an important step for new diagnostic and therapeutic approaches. The focus of interest on miRNAs as biomarkers came with new publications identifying free circulating extracellular miRNAs associated with various types of cancer. This study aimed to identify specific miRNAs in patients with osteoporotic fractures compared with nonosteoporotic fractures. For the array analysis, miRNAs were isolated from the serum of 20 patients with hip fractures, transcribed, and the samples were pooled into 10 osteoporotic and 10 nonosteoporotic specimens. With each pool of samples, human serum and plasma miRNA PCR arrays were performed, which are able to identify 83 different miRNAs. Subsequently, a separate validation analysis of each miRNA found to be regulated in the array followed with miRNA samples isolated from the serum of 30 osteoporotic and 30 nonosteoporotic patients and miRNA samples isolated from the bone tissue of 20 osteoporotic and 20 nonosteoporotic patients. With the validation analysis of the regulated miRNAs, we identified 9 miRNAs, namely miR-21, miR-23a, miR-24, miR-93, miR-100, miR-122a, miR-124a, miR-125b, and miR-148a, that were significantly upregulated in the serum of patients with osteoporosis. In the bone tissue of osteoporotic patients, we identified that miR-21, miR-23a, miR-24, miR-25, miR-100, and miR-125b displayed a significantly higher expression. A total of 5 miRNAs display an upregulation both in serum and bone tissue. This study reveals an important role for several miRNAs in osteoporotic patients and suggested that they may be used as biomarkers for diagnostic purposes and may be a target for treating bone loss and optimizing fracture healing in osteoporotic patients.

Keywords: miRNA; OSTEOPOROSIS; FRACTURE; BONE HEALING; BIOMARKERS

Links

DOI: 10.1002/jbmr.2175

PubMed: 24431276

WoS: 000340243900003

History

Received: 2013-09-12

Revised: 2013-12-22

Accepted: 2014-01-09

Online: 2014-01-16

Cited Works (3)

Year	Entry
2004	Schuit SCE, van der Klift M, Weel AEAM, de Laet CEDH, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JPTM, Pols HAP. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. January 2004;34(1):195-202.
2005	Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. December 2005;115(12):3318-3325.
2001	Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCT method. Methods. December 2001;25(4):402-408.

Cited By (18)

Year	Entry
2020	Zarecki P, Hackl M, Grillari J, Debono M, Eastell R. Serum microRNAs as novel biomarkers for osteoporotic vertebral fractures. Bone. January 2020;130:115113.
2020	Kocijan R, Weigl M, Skalicky S, Geiger E, Ferguson J, Leinfellner G, Heimel P, Pietschmann P, Grillari J, Redl H, Hackl M. MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis. Bone. February 2020;131:115104.
2020	Moura SR, Bras JP, Freitas J, Osório H, Barbosa MA, Santos SG, Almeida MI. miR-99a in bone homeostasis: regulating osteogenic lineage commitment and osteoclast differentiation. Bone. May 2020;134:115303.
2020	Verdelli C, Sansoni V, Perego S, Favero V, Vitale J, Terrasi A, Morotti A, Passeri E, Lombardi G, Corbetta S. Circulating fractures-related microRNAs distinguish primary hyperparathyroidism-related from estrogen withdrawal-related osteoporosis in postmenopausal osteoporotic women: a pilot study. Bone. August 2020;137:115350.
2020	Gu H, Shi S, Xiao F, Huang Z, Xu J, Chen G, Zhou K, Lu L, Yin X. MiR-1-3p regulates the differentiation of mesenchymal stem cells to prevent osteoporosis by targeting secreted frizzled-related protein 1. Bone. August 2020;137:115444.
2021	de Nigris F, Ruosi C, Colella G, Napoli C. Epigenetic therapies of osteoporosis. Bone. January 2021;142:115680.
2021	Potter ML, Hill WD, Isales CM, Hamrick MW, Fulzele S. MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells. Bone. January 2021;142:115679.
2021	Kaur T, John AA, Sharma C, Vashisht NK, Singh D, Kapila R, Kapila S. miR300 intervenes Smad3/β-catenin/RunX2 crosstalk for therapy with an alternate function as indicative biomarker in osteoporosis. Bone. February 2021;143:115603.
2021	Grillari J, Mäkitie RE, Kocijan R, Haschka J, Vázquez DC, Semmelrock E, Hackl M. Circulating miRNAs in bone health and disease. Bone. April 2021;145:115787.
2022	Anastasilakis AD, Papachatzopoulos S, Makras P, Gkiomisi A, Nikolakopoulos P, Polyzos SA, Ntenti C, Ballaouri I, Gerou S, Tsachouridou O, Papatheodorou A, Aliazis K, Fermanoglou S, Bisbinas I, Yavropoulou MP. The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis. Bone. May 2022;158:116354.
2022	Heilmeier U, Hackl M, Schroeder F, Torabi S, Kapoor P, Vierlinger K, Eiriksdottir G, Gudmundsson EF, Harris TB, Gudnason V, Link TM, Grillari J, Schwartz AV. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus. Bone. May 2022;158:116308.
2022	Jurado S, Parés A, Peris P, Combalia A, Monegal A, Guañabens N. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases. Bone. September 2022;162:116483.
2020	Ladang A, Beaudart C, Locquet M, Reginster J-Y, Bruyère O, Cavalier E. Evaluation of a panel of microRNAs that predicts fragility fracture risk: a pilot study. Calcif Tiss Int. March 2020;106(3):239-247.
2021	Kerschan-Schindl K, Hackl M, Boschitsch E, Föger-Samwald U, Nägele O, Skalicky S, Weigl M, Grillari J, Pietschmann P. Diagnostic performance of a panel of miRNAs (OsteomiR) for osteoporosis in a cohort of postmenopausal women. Calcif Tiss Int. June 2021;108(6):725-737.
2020	Gautvik KM, Günther C, Prijatelj V, Medina‐Gomez C, Shevroja E, Rad LH, Yazdani M, Lindalen E, Valland H, Gautvik VT, Olstad OK, Holden M, Rivadeneira F, Utheim TP, Reppe S. Distinct subsets of noncoding RNAs are strongly associated with BMD and fracture, studied in weight‐bearing and non–weight‐bearing human bone. J Bone Miner Res. June 2020;35(6):1065-1076.
2020	Legrand MA, Millet M, Merle B, Rousseau J, Hemmendinger A, Gineyts E, Sornay‐Rendu E, Szulc P, Borel O, Croset M, Chapurlat R. A signature of circulating miRNAs associated with fibrous dysplasia of bone: the mirDys study. J Bone Miner Res. October 2020;35(10):1881-1892.
2021	Nevola KT, Kiel DP, Zullo AR, Weiss S, Homuth G, Foessl I, Obermayer‐Pietsch B, Motyl KJ, Lary CW. miRNA mechanisms underlying the association of beta blocker use and bone mineral density. J Bone Miner Res. January 2021;36(1):110-122.
2019	Davis HM. Molecular Mechanisms Underlying Osteocyte Apoptosis and the Associated Osteoclastogenesis in Cx43-Deficiency and Aging [PhD thesis]. Indiana University – Purdue University Indianapolis (IUPUI); June 2019.